- Article
Reduced Plasma Aβ Peptides but Stable NfL and GFAP in Major Depressive Disorder
- María de los Ángeles Fernández-Ceballos,
- Lara Vidal-Nogueira,
- Carlos Fernández-Pereira,
- Pedro Fortes-González,
- Ángel Salgado-Barreira,
- Estrella Ledo-Matos,
- Elena Santana-Muriel,
- Tania Rivera-Baltanás,
- José Manuel Olivares and
- Roberto Carlos Agís-Balboa
- + 2 authors
2 February 2026
Major depressive disorder (MDD) has been associated with an increased risk of cognitive decline and neurodegenerative disorders like Alzheimer’s disease (AD), prompting interest in peripheral biomarkers related to amyloid metabolism as well as...

